LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

Emergent BioSolutions Inc

Suletud

SektorTervishoid

6.65 21.35

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

6.53

Max

6.68

Põhinäitajad

By Trading Economics

Sissetulek

-146M

-31M

Müük

-105M

189M

Aktsiakasum

0.71

Kasumimarginaal

-16.535

Töötajad

900

EBITDA

-164M

13M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+103.31% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

5. aug 2025

Turustatistika

By TradingEconomics

Turukapital

-223M

317M

Eelmine avamishind

-14.7

Eelmine sulgemishind

6.65

Uudiste sentiment

By Acuity

59%

41%

306 / 382 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Emergent BioSolutions Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

18. mai 2025, 23:47 UTC

Market Talk

Nikkei May Trade Rangebound Amid Uncertainty Over U.S. Tariffs -- Market Talk

18. mai 2025, 23:40 UTC

Market Talk

Gold Rises Amid Concerns Over U.S. Fiscal Deficit -- Market Talk

18. mai 2025, 18:00 UTC

Tulu

Tax Bill News; Target, Home Depot, and Snowflake Earnings; and More Stock Market News to Watch This Week -- Barrons.com

18. mai 2025, 17:01 UTC

Peamised uudised

GM Is Fighting California on EVs. This Is What It Wants to Overturn and Why. -- Barrons.com

18. mai 2025, 16:20 UTC

Tulu

Tesla Demand Hasn't Rebounded Yet. Watch China This Week. -- Barrons.com

18. mai 2025, 12:09 UTC

Peamised uudised

Trump Sounds Upbeat on Ukraine Cease-Fire as Russia Unleashes Drone Barrage -- WSJ

17. mai 2025, 17:15 UTC

Peamised uudised

Trump Attacks Walmart for Tariff-Related Price Increases -- WSJ

17. mai 2025, 09:30 UTC

Peamised uudised
Tulu

In a Trade War, Walmart Lacks Some of Amazon's Ammunition -- Heard on the Street -- WSJ

17. mai 2025, 08:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. mai 2025, 08:20 UTC

Market Talk
Tulu

Financial Services Roundup: Market Talk

16. mai 2025, 23:18 UTC

Peamised uudised

U.S. Loses Last Triple-A Credit Rating -- 2nd Update

16. mai 2025, 22:30 UTC

Peamised uudised

U.S. Loses Last Triple-A Credit Rating -- Update

16. mai 2025, 21:56 UTC

Market Talk

Fitch Raises Greece's Outlook to Positive From Stable -- Market Talk

16. mai 2025, 21:56 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16. mai 2025, 21:54 UTC

Peamised uudised

U.S. Loses Last Triple-A Credit Rating -- WSJ

16. mai 2025, 21:22 UTC

Market Talk

Moody's Says U.S. Fiscal Performance Likely to Deteriorate -- Market Talk

16. mai 2025, 21:17 UTC

Market Talk

Treasury Yields Rise, Dollar Falls After Moody's Cuts U.S. Credit Rating -- Market Talk

16. mai 2025, 21:17 UTC

Peamised uudised

The Score: UnitedHealth, Walmart, Coinbase Global and More Stocks That Moved on the Week's News -- WSJ

16. mai 2025, 21:05 UTC

Market Talk

Moody's Downgrades U.S. Credit Rating Due to Deficit, Debts -- Market Talk

16. mai 2025, 20:55 UTC

Omandamised, ülevõtmised, äriostud

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16. mai 2025, 20:50 UTC

Market Talk
Tulu

Financial Services Roundup: Market Talk

16. mai 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16. mai 2025, 20:37 UTC

Peamised uudised

Trade Progress Sparks Bullish Week for Wall Street -- WSJ

16. mai 2025, 20:33 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Dick's-Foot Locker Deal Looks Like a Bet on Nike's Turnaround -- Market Talk

16. mai 2025, 20:30 UTC

Omandamised, ülevõtmised, äriostud

Galaxy Digital Begins U.S. Trading as Bitcoin Keeps Powering Ahead -- Barrons.com

16. mai 2025, 20:18 UTC

Peamised uudised

Major U.S. Stock Indexes Rise; U.S. Running Out of Patience for Trade Deals -- WSJ

16. mai 2025, 20:16 UTC

Peamised uudised

Justice Department Wants to Spare Boeing From Guilty Plea Over 737 MAX Charges -- 3rd Update

16. mai 2025, 20:15 UTC

Tulu

Tesla Stock Rises. Even Hedge Fund Sales Can't Keep It Down. -- Barrons.com

16. mai 2025, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Henry Schein: William K. Daniel Joins Board

16. mai 2025, 20:10 UTC

Omandamised, ülevõtmised, äriostud

Henry Schein: Strategic Investment by KKR Completed

Võrdlus sarnastega

Hinnamuutus

Emergent BioSolutions Inc Prognoos

Hinnasiht

By TipRanks

103.31% tõus

12 kuu keskmine prognoos

Keskmine 13.5 USD  103.31%

Kõrge 15 USD

Madal 12 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Emergent BioSolutions Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

2

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

4.95 / N/AToetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Weak Bullish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Sentiment

By Acuity

306 / 382 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Emergent BioSolutions Inc

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It also provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; BAT for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Reactive Skin Decontamination Lotion Kit to remove or neutralize chemical warfare agents from the skin; Trobigard, a atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing CGRD-001 for the treatment of poisoning by organophosphorus nerve agents or organophosphorus compounds; EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; SIAN Antidote for initial treatment of certain or suspected acute cyanide poisoning; UniFlu for immunity against influenza A and B viruses; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.